[
  {
    "ts": null,
    "headline": "Transaction in Own Shares",
    "summary": "Transaction in Own Shares 10 February 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 10 February 2026 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of PurchaseNumber of Shares purchasedHighest price paid Lowest price paid Volume weighted average price paid per shareVenueCurrency10/02/2026357,25428.700028.125028.4169LSEGBP10/02/2026149,43028.700028.140028.4197Chi-X (CXE)GB",
    "url": "https://finnhub.io/api/news?id=89640e69d779f91629683ca50670dcb560d20333e6678612efe65057cbf66759",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770744180,
      "headline": "Transaction in Own Shares",
      "id": 139033739,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CBOE",
      "source": "Yahoo",
      "summary": "Transaction in Own Shares 10 February 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 10 February 2026 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of PurchaseNumber of Shares purchasedHighest price paid Lowest price paid Volume weighted average price paid per shareVenueCurrency10/02/2026357,25428.700028.125028.4169LSEGBP10/02/2026149,43028.700028.140028.4197Chi-X (CXE)GB",
      "url": "https://finnhub.io/api/news?id=89640e69d779f91629683ca50670dcb560d20333e6678612efe65057cbf66759"
    }
  },
  {
    "ts": null,
    "headline": "VERSES AI Inc. Announces Management Changes",
    "summary": "David T. Scott Appointed Interim CEO, Succeeding Gabriel René. Board Search for a Permanent CEO is Underway. VANCOUVER, British Columbia, Feb. 10, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, announces that the Company’s founders Gabriel René and Dan Mapes have each resigned for personal reasons from their positions with the Company as Chief Executive Officer",
    "url": "https://finnhub.io/api/news?id=92a22bec55bb68d10bf0d67e67a71107b9278d9aba177a522176130680fdbf69",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770730740,
      "headline": "VERSES AI Inc. Announces Management Changes",
      "id": 139029959,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CBOE",
      "source": "Yahoo",
      "summary": "David T. Scott Appointed Interim CEO, Succeeding Gabriel René. Board Search for a Permanent CEO is Underway. VANCOUVER, British Columbia, Feb. 10, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, announces that the Company’s founders Gabriel René and Dan Mapes have each resigned for personal reasons from their positions with the Company as Chief Executive Officer",
      "url": "https://finnhub.io/api/news?id=92a22bec55bb68d10bf0d67e67a71107b9278d9aba177a522176130680fdbf69"
    }
  },
  {
    "ts": null,
    "headline": "Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution",
    "summary": "Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLCProven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programsAppointed as Helus Pharma advances its pipeline toward key clinical milestones, including expected Phase 2",
    "url": "https://finnhub.io/api/news?id=e138fd042c125f081555b25d26de5b38236b4f4d4e4b9eebea8c187138ad127d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770726600,
      "headline": "Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution",
      "id": 139029960,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CBOE",
      "source": "Yahoo",
      "summary": "Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLCProven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programsAppointed as Helus Pharma advances its pipeline toward key clinical milestones, including expected Phase 2",
      "url": "https://finnhub.io/api/news?id=e138fd042c125f081555b25d26de5b38236b4f4d4e4b9eebea8c187138ad127d"
    }
  },
  {
    "ts": null,
    "headline": "OSB GROUP PLC - Transaction in Own Shares",
    "summary": "OSB GROUP PLC ISIN: GB00BLDRH36010 February 2026 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares The Company announces that on 09 February 2026 it had purchased a total of 103,251 of its ordinary shares of £0.01 each (the \"ordinary shares\") on the London Stock Exchange, CBOE BXE and CBOE CXE, through the Company's broker Citigroup Global Markets Limited as detailed below. The repurchased ordinary shares will be cancelled. London Stock ExchangeCBOE BXECBOE",
    "url": "https://finnhub.io/api/news?id=84a7ad468f48cf8b57eb4ef5d5637be475ef236d4e2386678875de8ff0d673aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770706800,
      "headline": "OSB GROUP PLC - Transaction in Own Shares",
      "id": 139027223,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CBOE",
      "source": "Yahoo",
      "summary": "OSB GROUP PLC ISIN: GB00BLDRH36010 February 2026 LEI number: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the “Company”) Transaction in Own Shares The Company announces that on 09 February 2026 it had purchased a total of 103,251 of its ordinary shares of £0.01 each (the \"ordinary shares\") on the London Stock Exchange, CBOE BXE and CBOE CXE, through the Company's broker Citigroup Global Markets Limited as detailed below. The repurchased ordinary shares will be cancelled. London Stock ExchangeCBOE BXECBOE",
      "url": "https://finnhub.io/api/news?id=84a7ad468f48cf8b57eb4ef5d5637be475ef236d4e2386678875de8ff0d673aa"
    }
  }
]